Trgovina Schrödinger, Inc. - SDGR CFD
Dodaj med priljubljene- Povzetek
- Zgodovinski podatki
- Dogodki
- Izkaz poslovnega izida
- Bilanca stanja
- Denarni tok
- Lastništvo
Razmik | 0.39 | ||||||||
Nočna pristojbina za nakup
Long position overnight fee
Pojdi na platformo | -0.024068% | ||||||||
Nočna pristojbina za prodajo
Short position overnight fee
Pojdi na platformo | 0.001846% | ||||||||
Čas nočne pristojbine | 21:00 (UTC) | ||||||||
Min. tržena količina | 1 | ||||||||
Valuta | USD | ||||||||
Kritje | 20% | ||||||||
Borza | United States of America | ||||||||
Provizija na trgovanje | 0% |
*Information provided by Capital.com
Predhodno. Zapri* | 26.51 |
Odpri* | 26.02 |
Enoletna sprememba* | -19.19% |
Dnevni razpon* | 25.55 - 26.38 |
Razpon 52 wk | 15.85-37.25 |
Povprečni obseg (10 dni) | 563.18K |
Povprečni obseg (3 meseci) | 12.36M |
Tržna kapitalizacija | 1.83B |
Razmerje P/E | -100.00K |
Število delnic v obtoku | 80.65M |
Prihodki | 180.96M |
EPS | -2.10 |
Dividenda (donosnost v %) | N/A |
Beta | -100.00K |
Datum naslednjega zaslužka | May 2, 2023 |
Vse podatke je zagotovil Refinitiv, razen podatkov, označenih z zvezdico, ki so *podatki, ki jih je zagotovil Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Zapiranje | Change | Change (%) | Odpiranje | High | Low |
---|---|---|---|---|---|---|
Mar 17, 2023 | 25.43 | -0.24 | -0.93% | 25.67 | 26.54 | 24.89 |
Mar 16, 2023 | 26.51 | 1.35 | 5.37% | 25.16 | 26.72 | 25.07 |
Mar 15, 2023 | 25.55 | 1.08 | 4.41% | 24.47 | 25.74 | 24.29 |
Mar 14, 2023 | 25.48 | 0.76 | 3.07% | 24.72 | 25.64 | 24.43 |
Mar 13, 2023 | 24.30 | 1.39 | 6.07% | 22.91 | 24.39 | 22.19 |
Mar 10, 2023 | 23.32 | -1.20 | -4.89% | 24.52 | 24.74 | 22.54 |
Mar 9, 2023 | 24.78 | -0.40 | -1.59% | 25.18 | 25.68 | 24.50 |
Mar 8, 2023 | 25.30 | 0.24 | 0.96% | 25.06 | 25.65 | 24.70 |
Mar 7, 2023 | 25.14 | 0.23 | 0.92% | 24.91 | 25.88 | 24.33 |
Mar 6, 2023 | 24.98 | -1.31 | -4.98% | 26.29 | 26.29 | 24.87 |
Mar 3, 2023 | 26.03 | 1.78 | 7.34% | 24.25 | 26.22 | 23.31 |
Mar 2, 2023 | 24.27 | 0.31 | 1.29% | 23.96 | 25.64 | 23.74 |
Mar 1, 2023 | 24.58 | -1.02 | -3.98% | 25.60 | 27.04 | 24.41 |
Feb 28, 2023 | 21.63 | 0.45 | 2.12% | 21.18 | 21.84 | 21.02 |
Feb 27, 2023 | 21.42 | -0.33 | -1.52% | 21.75 | 21.82 | 21.07 |
Feb 24, 2023 | 21.51 | -0.13 | -0.60% | 21.64 | 22.11 | 20.85 |
Feb 23, 2023 | 22.30 | -0.13 | -0.58% | 22.43 | 22.83 | 21.87 |
Feb 22, 2023 | 22.48 | -0.49 | -2.13% | 22.97 | 23.15 | 22.12 |
Feb 21, 2023 | 22.82 | -0.26 | -1.13% | 23.08 | 23.64 | 22.80 |
Feb 17, 2023 | 23.71 | 0.01 | 0.04% | 23.70 | 23.85 | 23.02 |
Schrödinger, Inc. Events
Čas (UTC) (UTC) | Država | Dogodek |
---|---|---|
No events scheduled |
- Letni
- Četrtletno
2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|
Skupni prihodki | 55.693 | 66.639 | 85.543 | 108.095 | 137.931 |
Prihodki | 55.693 | 66.639 | 85.543 | 108.095 | 137.931 |
Celotni stroški prihodkov | 15.893 | 23.702 | 36.45 | 44.623 | 72.311 |
Bruto dobiček | 39.8 | 42.937 | 49.093 | 63.472 | 65.62 |
Celotni odhodki iz poslovanja | 74.714 | 94.608 | 124.258 | 169.011 | 249.374 |
Celotna prodaja/splošni/upravni stroški Odhodki | 31.152 | 34.259 | 46.291 | 59.693 | 86.159 |
Raziskave in razvoj | 27.669 | 34.215 | 38.786 | 64.695 | 90.904 |
Prihodki iz poslovanja | -19.021 | -27.969 | -38.715 | -60.916 | -111.443 |
Prihodki (odhodki) od obresti, neto Neoperativni | 1.961 | -0.379 | 12.743 | 34.624 | 10.635 |
Čisti dobiček pred obdavčitvijo | -17.06 | -28.348 | -25.972 | -26.292 | -100.808 |
Čisti dobiček po davkih | -17.392 | -28.425 | -25.681 | -26.637 | -101.219 |
Čisti dobiček pred dodatnimi postavkami | -17.392 | -28.425 | -24.571 | -24.463 | -100.393 |
Skupaj izredne postavke | 0 | ||||
Čisti dobiček | -17.392 | -28.425 | -24.571 | -24.463 | -100.393 |
Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | -17.392 | -28.425 | -24.571 | -24.463 | -100.393 |
Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | -17.392 | -28.425 | -24.571 | -24.463 | -100.393 |
Popravljen čisti dobiček | -17.392 | -28.425 | -24.571 | -24.463 | -100.393 |
Popravljene ponderirane povprečne delnice | 61.4472 | 61.4472 | 61.4472 | 60.0247 | 70.5949 |
Popravljen dobiček na delnico brez upoštevanja izrednih postavk | -0.28304 | -0.46259 | -0.39987 | -0.40755 | -1.4221 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | |||
Popravljen normalizirani dobiček na enoto čistega dobička | -0.28304 | -0.46259 | -0.39987 | -0.40755 | -1.4221 |
Depreciation / Amortization | 2.432 | 2.731 | |||
Manjšinski delež | 1.11 | 2.174 | 0.826 |
Q1 2021 | Q2 2021 | Q3 2021 | Q4 2021 | Q1 2022 | |
---|---|---|---|---|---|
Skupni prihodki | 32.127 | 29.784 | 29.85 | 46.17 | 48.663 |
Prihodki | 32.127 | 29.784 | 29.85 | 46.17 | 48.663 |
Celotni stroški prihodkov | 15.963 | 17.804 | 18.735 | 19.809 | 20.68 |
Bruto dobiček | 16.164 | 11.98 | 11.115 | 26.361 | 27.983 |
Celotni odhodki iz poslovanja | 56.039 | 60.126 | 64.524 | 68.685 | 77.306 |
Celotna prodaja/splošni/upravni stroški Odhodki | 18.628 | 21.23 | 22.57 | 23.731 | 28.804 |
Raziskave in razvoj | 21.448 | 21.092 | 23.219 | 25.145 | 27.822 |
Prihodki iz poslovanja | -23.912 | -30.342 | -34.674 | -22.515 | -28.643 |
Prihodki (odhodki) od obresti, neto Neoperativni | 23.463 | -4.561 | -0.341 | -7.926 | -5.836 |
Čisti dobiček pred obdavčitvijo | -0.449 | -34.903 | -35.015 | -30.441 | -34.479 |
Čisti dobiček po davkih | -0.523 | -34.97 | -35.011 | -30.715 | -34.451 |
Manjšinski delež | 0.494 | 0.326 | 0.004 | 0.002 | 0.011 |
Čisti dobiček pred dodatnimi postavkami | -0.029 | -34.644 | -35.007 | -30.713 | -34.44 |
Čisti dobiček | -0.029 | -34.644 | -35.007 | -30.713 | -34.44 |
Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | -0.029 | -34.644 | -35.007 | -30.713 | -34.44 |
Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | -0.029 | -34.644 | -35.007 | -30.713 | -34.44 |
Popravljen čisti dobiček | -0.029 | -34.644 | -35.007 | -30.713 | -34.44 |
Popravljene ponderirane povprečne delnice | 70.0716 | 70.5821 | 70.7842 | 70.9341 | 71.0504 |
Popravljen dobiček na delnico brez upoštevanja izrednih postavk | -0.00041 | -0.49083 | -0.49456 | -0.43298 | -0.48473 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Popravljen normalizirani dobiček na enoto čistega dobička | -0.00041 | -0.49083 | -0.49456 | -0.43298 | -0.48473 |
- Letni
- Četrtletno
2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|
Kratkoročna sredstva skupaj | 48.054 | 104.69 | 118.536 | 682.978 | 625.06 |
Denarna sredstva in kratkoročne naložbe | 36.343 | 84.067 | 85.83 | 642.691 | 576.479 |
Denarna sredstva in ustrezniki | 9.96 | 77.716 | 25.986 | 202.296 | 120.267 |
Kratkoročne naložbe | 26.383 | 6.351 | 59.844 | 440.395 | 456.212 |
Celotne terjatve, neto | 9.759 | 18.021 | 25.738 | 35.378 | 40.551 |
Accounts Receivable - Trade, Net | 9.759 | 17.995 | 25.58 | 35.012 | 40.015 |
Prepaid Expenses | 1.952 | 2.602 | 6.468 | 4.409 | 5.03 |
Total Assets | 58.022 | 120.73 | 155.27 | 746.263 | 756.487 |
Property/Plant/Equipment, Total - Net | 5.439 | 7.967 | 19.03 | 15.269 | 85.409 |
Property/Plant/Equipment, Total - Gross | 14.677 | 17.4 | 29.592 | 29.071 | 97.764 |
Accumulated Depreciation, Total | -9.238 | -9.433 | -10.562 | -13.802 | -12.355 |
Intangibles, Net | 0.052 | 0.015 | 0 | ||
Long Term Investments | 2.609 | 5.444 | 15.366 | 45.664 | 43.167 |
Other Long Term Assets, Total | 1.868 | 2.614 | 2.338 | 2.352 | 2.851 |
Total Current Liabilities | 17.818 | 27.005 | 45.02 | 73.205 | 91.211 |
Accounts Payable | 1.61 | 2.773 | 3.524 | 8.398 | 8.079 |
Accrued Expenses | 5.052 | 6.587 | 16.442 | 19.404 | 27.764 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 11.156 | 17.645 | 25.054 | 45.403 | 55.368 |
Total Liabilities | 21.074 | 30.603 | 57.054 | 122.248 | 199.416 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Liabilities, Total | 3.256 | 3.598 | 11.993 | 49.039 | 108.191 |
Total Equity | 36.948 | 90.127 | 98.216 | 624.015 | 557.071 |
Preferred Stock - Non Redeemable, Net | 82.31 | 161.687 | 191.58 | 0 | |
Common Stock | 0.055 | 0.059 | 0.061 | 0.699 | 0.71 |
Additional Paid-In Capital | 6.71 | 8.915 | 11.655 | 752.558 | 786.964 |
Retained Earnings (Accumulated Deficit) | -52.1 | -80.525 | -105.096 | -129.559 | -229.952 |
Other Equity, Total | -0.027 | -0.009 | 0.016 | 0.317 | -0.651 |
Total Liabilities & Shareholders’ Equity | 58.022 | 120.73 | 155.27 | 746.263 | 756.487 |
Total Common Shares Outstanding | 61.4472 | 61.4472 | 61.4472 | 69.8777 | 70.9987 |
Other Current Assets, Total | 0.5 | 0.5 | 3 | ||
Minority Interest | 0.041 | 0.004 | 0.014 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Kratkoročna sredstva skupaj | 675.238 | 649.788 | 622.025 | 625.06 | 586.168 |
Denarna sredstva in kratkoročne naložbe | 648.494 | 613.591 | 597.186 | 576.479 | 525.532 |
Denarna sredstva in ustrezniki | 133.122 | 117.699 | 160.879 | 120.267 | 117.257 |
Kratkoročne naložbe | 515.372 | 495.892 | 436.307 | 456.212 | 408.275 |
Celotne terjatve, neto | 18.29 | 25.904 | 16.33 | 40.551 | 45.594 |
Accounts Receivable - Trade, Net | 17.974 | 25.953 | 16.347 | 40.015 | 44.086 |
Prepaid Expenses | 7.954 | 7.293 | 5.509 | 5.03 | 11.542 |
Other Current Assets, Total | 0.5 | 3 | 3 | 3 | 3.5 |
Total Assets | 744.189 | 717.334 | 762.617 | 756.487 | 719.537 |
Property/Plant/Equipment, Total - Net | 13.664 | 14.451 | 85.533 | 85.409 | 89.256 |
Long Term Investments | 52.931 | 49.713 | 51.087 | 43.167 | 37.002 |
Other Long Term Assets, Total | 2.356 | 3.382 | 3.972 | 2.851 | 1.334 |
Total Current Liabilities | 67.621 | 70.378 | 72.916 | 91.211 | 85.532 |
Accounts Payable | 7.22 | 5.96 | 8.228 | 8.079 | 9.766 |
Accrued Expenses | 19.642 | 20.349 | 20.814 | 27.764 | 21.995 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 40.759 | 44.069 | 43.874 | 55.368 | 53.771 |
Total Liabilities | 112.421 | 111.583 | 182.811 | 199.416 | 188.87 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0.008 | 0.02 | 0.016 | 0.014 | 0.003 |
Other Liabilities, Total | 44.792 | 41.185 | 109.879 | 108.191 | 103.335 |
Total Equity | 631.768 | 605.751 | 579.806 | 557.071 | 530.667 |
Common Stock | 0.705 | 0.708 | 0.709 | 0.71 | 0.712 |
Additional Paid-In Capital | 760.574 | 769.199 | 778.292 | 786.964 | 797.004 |
Retained Earnings (Accumulated Deficit) | -129.588 | -164.232 | -199.239 | -229.952 | -264.392 |
Other Equity, Total | 0.077 | 0.076 | 0.044 | -0.651 | -2.657 |
Total Liabilities & Shareholders’ Equity | 744.189 | 717.334 | 762.617 | 756.487 | 719.537 |
Total Common Shares Outstanding | 70.4649 | 70.7178 | 70.8676 | 70.9987 | 71.1366 |
Goodwill, Net | 4.791 | ||||
Intangibles, Net | 0.986 |
- Letni
- Četrtletno
2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|
Čisti prihodki/začetna postavka | -17.392 | -28.425 | -25.681 | -26.637 | -101.219 |
Denarna sredstva iz poslovanja | -15.307 | -23.711 | -26.059 | 16.757 | -70.669 |
Denarna sredstva iz poslovanja | 1.685 | 2.894 | 3.64 | 3.658 | 2.847 |
Nedenarne postavke | -1.188 | 1.539 | -8.313 | -19.44 | 23.026 |
Cash Taxes Paid | 0.348 | 0.013 | 0.139 | 0.381 | 0.448 |
Spremembe v obratnem kapitalu | 1.588 | 0.281 | 4.295 | 59.176 | 4.677 |
Denarna sredstva pri naložbenju | 2.049 | 11.194 | -53.855 | -381.721 | -16.812 |
Kapitalski izdatki | -3.7 | -5.259 | -1.836 | -2.538 | -7.167 |
Celotne druge postavke denarnih tokov pri naložbenju | 5.749 | 16.453 | -52.019 | -379.183 | -9.645 |
Denarna sredstva pri financiranju | 1.129 | 80.273 | 28.684 | 541.274 | 7.952 |
Izdaja (odplačilo) delnic, neto | 1.129 | 80.273 | 30.442 | 541.274 | 7.927 |
Neto sprememba denarnih sredstev | -12.129 | 67.756 | -51.23 | 176.31 | -79.529 |
Postavke denarnega toka pri financiranju | -1.758 | 0 | 0.025 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -0.523 | -35.493 | -70.504 | -101.219 | -34.451 |
Cash From Operating Activities | -10.921 | -40.293 | -50.931 | -70.669 | -39.722 |
Cash From Operating Activities | 0.887 | 1.614 | 2.195 | 2.847 | 0.969 |
Non-Cash Items | -16.21 | -3.581 | 7.164 | 23.026 | 16.798 |
Cash Taxes Paid | 0.119 | 0.224 | 0.236 | 0.448 | 0.037 |
Changes in Working Capital | 4.925 | -2.833 | 10.214 | 4.677 | -23.038 |
Cash From Investing Activities | -61.909 | -47.097 | 5.279 | -16.812 | 36.304 |
Capital Expenditures | -0.513 | -3.427 | -6.21 | -7.167 | -1.696 |
Other Investing Cash Flow Items, Total | -61.396 | -43.67 | 11.489 | -9.645 | 38 |
Cash From Financing Activities | 3.656 | 5.293 | 6.735 | 7.952 | 0.908 |
Issuance (Retirement) of Stock, Net | 3.656 | 5.268 | 6.71 | 7.927 | 0.908 |
Net Change in Cash | -69.174 | -82.097 | -38.917 | -79.529 | -2.51 |
Financing Cash Flow Items | 0.025 | 0.025 | 0.025 |
Ime vlagatelja | Vrsta vlagatelja | Odstotek neporavnanih obveznosti | Delnice v lasti | Sprememba delnic | Datum imetništva | Ocena prometa |
---|---|---|---|---|---|---|
Bill & Melinda Gates Foundation Trust | Endowment Fund | 11.2027 | 6981664 | 0 | 2022-12-31 | MED |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 8.1958 | 5107748 | 63870 | 2022-12-31 | LOW |
ARK Investment Management LLC | Investment Advisor | 6.1809 | 3852037 | 87330 | 2022-12-31 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 5.5071 | 3432108 | 214844 | 2022-12-31 | LOW |
Credit Suisse Asset Management | Investment Advisor/Hedge Fund | 4.158 | 2591296 | 349109 | 2022-12-31 | LOW |
Nikko Asset Management Co., Ltd. | Investment Advisor/Hedge Fund | 4.0185 | 2504407 | 94630 | 2022-12-31 | LOW |
Schrodinger Equity Holdings LLC | Corporation | 3.847 | 2397513 | -7260829 | 2021-12-01 | |
Baillie Gifford & Co. | Investment Advisor | 2.9233 | 1821858 | 640051 | 2022-12-31 | LOW |
Point72 Asset Management, L.P. | Hedge Fund | 2.2808 | 1421435 | 1421435 | 2022-12-31 | HIGH |
Friesner (Richard A) | Individual Investor | 1.97 | 1227703 | 0 | 2022-04-19 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 1.8294 | 1140112 | 79505 | 2022-12-31 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.618 | 1008367 | 24525 | 2022-12-31 | LOW |
Rubric Capital Management LP | Hedge Fund | 1.6046 | 1000000 | -77621 | 2022-12-31 | MED |
Stephens Investment Management Group, LLC | Investment Advisor | 1.2511 | 779715 | 3183 | 2022-12-31 | LOW |
Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 1.1777 | 733941 | 195764 | 2022-12-31 | LOW |
ACATIS Investment Kapitalverwaltungsgesellschaft GmbH | Investment Advisor | 1.1686 | 728300 | 0 | 2023-01-31 | LOW |
Invus Public Equities Advisors, LLC | Investment Advisor | 1.1232 | 700000 | 0 | 2022-12-31 | LOW |
Tocqueville Asset Management LP | Investment Advisor/Hedge Fund | 1.0707 | 667285 | 296005 | 2022-12-31 | LOW |
Pertento Partners LLP | Investment Advisor | 1.0213 | 636507 | 32824 | 2022-12-31 | MED |
Baron Capital Management, Inc. | Investment Advisor/Hedge Fund | 0.9941 | 619545 | -88259 | 2022-12-31 | LOW |
Zakaj izbrati Capital.com? Številke govorijo same zase.
Capital.com GroupBorzni posredniki
Aktivne stranke mesečno
Mesečni obseg naložb
Dvigi vsak mesec
Kalkulator trgovanja
Izračunajte svoj hipotetični P&L, če bi trgovino s CFD odprli na določen datum (izberite datum) in jo zaprli na drug datum (izberite datum).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Schrödinger, Inc. Company profile
O družbi Schrödinger, Inc.
Družba Schrodinger, Inc. je razvila na fiziki temelječo programsko platformo, ki omogoča odkrivanje molekul za razvoj zdravil in uporabo materialov. Programsko platformo uporabljajo biofarmacevtska in industrijska podjetja, akademske ustanove in vladni laboratoriji po vsem svetu. Družba svojo programsko platformo uporablja tudi za pospeševanje programov sodelovanja in lastnega nabora terapevtskih izdelkov za reševanje nezadovoljenih medicinskih potreb. Družba posluje v dveh segmentih: programska oprema in odkrivanje zdravil. Segment programske opreme se osredotoča na prodajo svoje programske opreme za preoblikovanje odkrivanja zdravil v industriji znanosti o življenju, pa tudi strankam v industriji znanosti o materialih. Segment odkrivanja zdravil je osredotočen na oblikovanje portfelja predkliničnih in kliničnih programov, interno in prek sodelovanja, ki so napredovali do različnih stopenj odkrivanja in razvoja. Med programi družbe za odkrivanje zdravil so MALT1, CDC7, Wee1 in SOS1/KRAS.
Industry: | Software (NEC) |
1540 Broadway
24Th Floor
NEW YORK
NEW YORK 10036
US
Izkaz poslovnega izida
- Annual
- Quarterly
Ljudje gledajo tudi
Še vedno iščete posrednika, ki mu lahko zaupate?
Pridružite se 500.000+ trgovcem po vsem svetu, ki so se odločili za trgovanje s Capital.com